Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen J Bagley
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
110 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Ontario
Ontario, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Memorial Hospital North
Colorado Springs, Colorado, United States
- Uchealth Memorial Hospital Central
Colorado Springs, Colorado, United States
- Cancer Care and Hematology-Fort Collins
Fort Collins, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Uchealth Greeley Hospital
Greeley, Colorado, United States
- Medical Center of the Rockies
Loveland, Colorado, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
- Baptist Md Anderson Cancer Center
Jacksonville, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Orlando Health Cancer Institute
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Rush Md Anderson Cancer Center
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
- Illinois Cancercare-Macomb
Macomb, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2022
- Primary completion
- 15 Jun 2025
- Completion
- 4 Sept 2026
- Last update posted
- 1 Apr 2026
- Registered enrollment
- 59
- Registry id
- NCT04729959
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.